Spectrum Pharmaceuticals
SPPI
#8445
Rank
โ‚ฌ0.18 B
Marketcap
0,88ย โ‚ฌ
Share price
0.00%
Change (1 day)
6.21%
Change (1 year)

Revenue for Spectrum Pharmaceuticals (SPPI)

Revenue in 2023 (TTM): โ‚ฌ23.8 Million

According to Spectrum Pharmaceuticals 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ22.09 Million. In 2022 the company made a revenue of โ‚ฌ9.42 Million an increase over the revenue in the year 2021 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Spectrum Pharmaceuticals from 1996 to 2023

Annual revenue

Year Revenue Change
2023 (TTM) โ‚ฌ23.8 M152.46%
2022 โ‚ฌ9.42 M
2021 N/A
2020 N/A
2019 N/A-100%
2018 โ‚ฌ95.57 M-10.67%
2017 โ‚ฌ0.10 B-23.16%
2016 โ‚ฌ0.13 B-6.35%
2015 โ‚ฌ0.14 B-3.22%
2014 โ‚ฌ0.15 B36.12%
2013 โ‚ฌ0.11 B-24.86%
2012 โ‚ฌ0.15 B1.08%
2011 โ‚ฌ0.14 B166.67%
2010 โ‚ฌ55.71 M109.94%
2009 โ‚ฌ26.53 M
2007 โ‚ฌ5.25 M
2002 โ‚ฌ2.26 M4772.87%
2001 โ‚ฌ0.04 M1461777.33%
2000 โ‚ฌ0 M-100%
1999 โ‚ฌ0.19 M-21.38%
1998 โ‚ฌ0.25 M0%
1997 โ‚ฌ0.25 M0%
1996 โ‚ฌ0.25 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Teva Pharmaceutical Industries
TEVA
โ‚ฌ14.40 B 65,102.69%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Seagen
SGEN
โ‚ฌ1.97 B 8,840.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
โ‚ฌ10 M-54.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚ฌ8.64 B 39,022.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ41.25 B 186,592.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚ฌ37.65 B 170,303.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ48.41 B 218,999.07%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Johnson & Johnson
JNJ
โ‚ฌ79.14 B 358,052.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ53.92 B 243,928.14%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚ฌ36.37 B 164,511.05%๐Ÿ‡ฌ๐Ÿ‡ง UK